INTEGRATING THE LONG-TERM HEALTH BURDEN OF ORAL CORTICOSTEROIDS IN THE COST-EFFECTIVENESS OF OMALIZUMAB

被引：0
|
作者：
Faria, R. [1 ]
McKenna, C. [1 ]
机构：
[1] Univ York, York YO10 5DD, N Yorkshire, England
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.292
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A373 / A373
页数：1
相关论文
共 50 条
  • [1] Recognising the long-term burden of short course oral corticosteroids
    Heaney, Liam G.
    Schleich, Florence
    Korn, Stephanie
    Howarth, Peter
    Antoun, Zeina Eid
    Bourdin, Arnaud
    Canonica, Giorgio W.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [2] Long-term cost-effectiveness of rimonabant in Germany
    Pirk, O.
    Hessel, F.
    Kotowa, W.
    Hertel, N.
    [J]. VALUE IN HEALTH, 2007, 10 (06) : A414 - A415
  • [3] The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
    Malkin, Samuel J. P.
    Carvalho, Davide
    Costa, Catarina
    Conde, Vasco
    Hunt, Barnaby
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [4] The long-term cost-effectiveness of oral semaglutide versus empagliflozin and dulaglutide in Portugal
    Samuel J. P. Malkin
    Davide Carvalho
    Catarina Costa
    Vasco Conde
    Barnaby Hunt
    [J]. Diabetology & Metabolic Syndrome, 14
  • [5] IMPACT OF METABOLIC SURGERY ON COST AND LONG-TERM HEALTH OUTCOME: A COST-EFFECTIVENESS APPROACH
    Walter, E.
    Langer, F.
    Beckerhinn, M.
    Hoffer, F.
    Prager, G.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A557 - A557
  • [6] Impact of metabolic surgery on cost and long-term health outcome: a cost-effectiveness approach
    Walter, Evelyn
    Langer, Felix B.
    Beckerhinn, Philipp
    Hoffer, Franz
    Prager, Gerhard
    [J]. SURGERY FOR OBESITY AND RELATED DISEASES, 2022, 18 (02) : 260 - 270
  • [7] Long-term costs and cost-effectiveness of adjunctive corticosteroids for patients with septic shock in New Zealand
    Thompson, Kelly J.
    Young, Paul J.
    Venkatesh, Balasubramanian
    Cohen, Jeremy
    Finfer, Simon R.
    Grattan, Sarah
    Hammond, Naomi E.
    Jan, Stephen
    Li, Qiang
    Di Tanna, Gian Luca
    McArthur, Colin
    Myburgh, John
    Rajbhandari, Dorrilyn
    Taylor, Colman B.
    [J]. AUSTRALIAN CRITICAL CARE, 2022, 35 (03) : 241 - 250
  • [8] The Cost-Effectiveness of Oral Semaglutide in Spain: A Long-Term Health Economic Analysis Based on the PIONEER Clinical Trials
    Franch-Nadal, Josep
    Malkin, Samuel J. P.
    Hunt, Barnaby
    Martin, Virginia
    Gallego Estebanez, Maria
    Vidal, Josep
    [J]. ADVANCES IN THERAPY, 2022, 39 (07) : 3180 - 3198
  • [9] The Cost-Effectiveness of Oral Semaglutide in Spain: A Long-Term Health Economic Analysis Based on the PIONEER Clinical Trials
    Josep Franch-Nadal
    Samuel J. P. Malkin
    Barnaby Hunt
    Virginia Martín
    María Gallego Estébanez
    Josep Vidal
    [J]. Advances in Therapy, 2022, 39 : 3180 - 3198
  • [10] Long-Term Cost-Effectiveness of a Diabetes Risk Score
    Sullivan, Sean D.
    Pollock, Richard
    Garrison, Louis P.
    Rinde, Harald
    Kolberg, Janice A.
    [J]. DIABETES, 2009, 58 : A44 - A44
12345